BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20170101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20170101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180307
DTEND;VALUE=DATE:20180309
DTSTAMP:20260515T074312
CREATED:20171212T070945Z
LAST-MODIFIED:20171212T070945Z
UID:5264-1520380800-1520553599@www.pharmajournalist.com
SUMMARY:Clinical Trial Supply New England
DESCRIPTION:The 7th Annual Clinical Trial Supply New England is back in 2018 on the 7th-8th March for what promises to be a fantastic event. The perfect event for all biotech’s and pharma companies in the New England region to come together and explore the latest issues\, trends and technologies within the clinical supply world. \nUnderstanding the characteristics of the region\, we have created a two days conference with full of sessions that will be an interest of smaller pharma and biotechs. It is all geared up with fresh up-to-date topics that you can learn from how your peers in the industry are managing the challenges and seek for new strategies from thought-provoking discussions. \nHere is the preview of two key topics for the 2017 event. \nImport and export regulation \nNo one likes getting unexpected bills. So do you. Marco Afonso\, Supervisory Import Specialist at U.S. Customs and Border Protection will be presenting a detailed exploration the evolving landscape of importing clinical trial materials and products into the US specifically investigating the key facts all companies should know when importing to the US to clarify your obligations to tax\, VAT and regulatory transgressions. \nContingency planning for natural disasters \nAs climate change worsens and typical weather patterns are altered resulting in unforeseen natural phenomena it is paramount of the industry to be able to react in a quick\, seamless manager when typical supply chain routes are disrupted. Chad Presher\, Associate Director\, Clinical Drug Supply\, Biogen will be presenting a case study which will among other things\, focus on the implications of hurricane Harvey on clinical trials to better prepare responses to ensure trial supply reaches the site
URL:https://www.pharmajournalist.com/event/clinical-trial-supply-new-england/
LOCATION:Boston\, MA
ORGANIZER;CN="Arena International":MAILTO:Events@arena-international.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180312
DTEND;VALUE=DATE:20180314
DTSTAMP:20260515T074312
CREATED:20171106T102949Z
LAST-MODIFIED:20171107T021556Z
UID:3811-1520812800-1520985599@www.pharmajournalist.com
SUMMARY:2nd Digital Pharma Multichannel Marketing Boot Camp West
DESCRIPTION:The 2nd Digital Pharma Multichannel Marketing Boot Camp West uses a combination of lectures\, class discussions and hands-on exercises with people who want to understand how to create effective and sophisticated digital and multichannel marketing (MCM) strategies. This intensive\, two-day program not only teaches you strategic processes\, it also gives you the tools and skills you need to gather insights and develop your own digital and multichannel programs. \nTo learn more about this event\, and to register online\, visit http://digitalpharmaseries.com/bootcamp \n 
URL:https://www.pharmajournalist.com/event/2nd-digital-pharma-multichannel-marketing-boot-camp-west/
LOCATION:Hilton San Francisco Airport Bayfront\, 600 Airport Boulevard\, Burlingame\, CA\, 94010\, United States
ORGANIZER;CN="ExL Events":MAILTO:digitalpharma@exlevents.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180313
DTEND;VALUE=DATE:20180315
DTSTAMP:20260515T074312
CREATED:20171213T031929Z
LAST-MODIFIED:20171213T031929Z
UID:5302-1520899200-1521071999@www.pharmajournalist.com
SUMMARY:Outsourcing in Clinical Trials Southeast
DESCRIPTION:For the 7th Outsourcing in Clinical Trials conference we will once again be welcoming a number of senior industry peers who given their experience will present\, debate and drive the conversation over our two day event. In 2018 you will be given the opportunity to delve straight into the big hot topics facing your outsourcing and operational challenges with regards to clinical trials and be prepared to address the changes facing the industry\, ensuing you are fully equipped for the future. \nSome hot topics highlights which we will be addressing at next year’s event are: \n– Uncovering ways through which you can manage your vendors without duplicating tasks\, affecting trial integrity and increasing in-house responsibilities \n– Improving staff recruitment; discussing how industry and academia can work together to ensure adequate training for future clinical trial staff to ensure trials are not compromised \n– To outsource or not to outsource\, this is the question? Examining the arguments behind keeping capabilities in house versus contracting out \n– Approaching funding opportunities strategically; which funding options are available for small-midsize pharma and biotech to boost your pipeline \nThese sessions will endeavour not only to answer questions\, but to open the floor to discussion so that sponsors and vendors alike can interact with one another and discover ways through which relationships and expectations can be best managed. With panel discussions\, debates and presentations\, this year’s program is certain to provide a platform for each and every delegate to explore the challenges affecting them and what feasible solutions could be adopted to solve these.
URL:https://www.pharmajournalist.com/event/outsourcing-clinical-trials-southeast/
LOCATION:Durham\, North Carolina
ORGANIZER;CN="Arena International":MAILTO:Events@arena-international.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180313
DTEND;VALUE=DATE:20180315
DTSTAMP:20260515T074312
CREATED:20180103T025327Z
LAST-MODIFIED:20180103T025445Z
UID:6477-1520899200-1521071999@www.pharmajournalist.com
SUMMARY:Pharmaceutical Compliance Congress (PCC) Asia
DESCRIPTION:Uncover the Risks Associated with Anti-Bribery and Anti-Corruption\, Data Privacy and HCP Engagement\n \nBacked by 20 years of global compliance programming and education\, CBI’s Pharmaceutical Compliance Congress (PCC) Asia is the premier event for compliance teams to gain novel approaches and advanced strategies for the quickly transforming regulatory landscape. \nWith rapidly evolving global regulations deeply affecting business operations in Asia\, multi-national life sciences companies must be more attentive than ever. Increasing anti-bribery and anti-corruption requirements from the U.S.\, UK and local Asian regulatory bodies are driving compliance professionals to build and maintain effective compliance programs that not only meet these multi-jurisdictional requirements\, but align with their overall business objectives. \nThis fully-packed two day forum features in-depth content and insights around the most important compliance and legal issues in China\, South Korea\, Japan\, Indonesia\, India\, Thailand\, Vietnam\, Malaysia\, the Philippines and Australia. Join the brightest minds and most influential stakeholders in life sciences compliance to benchmark\, exchange strategies and learn about the latest guidance and laws\, surrounding bribery and corruption\, HCP engagement\, transparency\, data privacy\, competition\, intellectual property and more. \nTo learn more about this event\, and to register online\, visit www.cbinet.com/PCCAsia
URL:https://www.pharmajournalist.com/event/pharmaceutical-compliance-congress-pcc-asia/
LOCATION:Grand Hyatt Shanghai\, Jin Mao Tower 88 Century Avenue\, Pudong\, Shanghai\, 200121\, China
ORGANIZER;CN="CBI%2C a division of UBM Americas":MAILTO:cbireg@cbinet.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180314
DTEND;VALUE=DATE:20180316
DTSTAMP:20260515T074312
CREATED:20171108T070708Z
LAST-MODIFIED:20171108T070708Z
UID:3860-1520985600-1521158399@www.pharmajournalist.com
SUMMARY:Clinical Trial Supply Europe 2018
DESCRIPTION:CTS Europe will be returning for the 19th edition next March. This prestigious event will welcome   representatives from 6 of the top 10 pharmaceutical companies in Europe\, who will be joined by leading biotech companies across the continent to jointly find solutions for your clinical trial supply problems and discuss changes in the industry. \nAs a streamed event this conference promises to address a larger variety of topics\, with sessions covering all the essentials in clinical supply\, from maximising forecasting software to patient centric strategies for supply chain and considering methods to achieve last mile delivery. \n2018 Key Speakers: \n– Jan-Pieter Kappelle\, Senior Director\, Clinical Trial Supplies\, UCB\n– Henk Mollee\, Senior Director\, CTM Manufacturing\, Astellas Pharmaceuticals\n– Niklas Mattsson\, Lead Comparator Sourcing and Planning\, MSD\n– Alison Meyers\, Director Clinical Liaison Lead\, Clinical Interface\, GlaxoSmithKline\n– Ross MacRae\, Senior Director Clinical Manufacturing\, Pfizer\n– Erik Meyer\, Director Clinical Trial Supply\, Merck\n– Peter Orosz\, Head of Clinical Supply Chain Management & Oncology\, Boehringer Ingelheim\n– Alex Robertson\, Senior Director\, Supply Chain Management\, AstraZeneca \nTo learn more about this event\, and to register online\, visit http://www.arena-international.com/ctseurope
URL:https://www.pharmajournalist.com/event/clinical-trial-supply-europe-2018/
LOCATION:Milan\, Italy
ORGANIZER;CN="Arena International Events Group":MAILTO:events@arena-international.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180314
DTEND;VALUE=DATE:20180316
DTSTAMP:20260515T074312
CREATED:20171108T071214Z
LAST-MODIFIED:20171108T071236Z
UID:3865-1520985600-1521158399@www.pharmajournalist.com
SUMMARY:Temperature Maintenance of Biopharmaceuticals in Distribution 2018
DESCRIPTION:After an incredibly successful Temperature Maintenance of Biopharmaceuticals in Distribution event\, we are excited to announce the event programme for this year’s event! \nOur 2017 programme provided a holistic approach to temperature controlled shipments whilst also addressing transportation obstacles and regulatory compliance. Topics included transportation\, GDP compliance\, qualification systems and case studies from both cold chain and ambient product perspectives. \nWhether you are from a small biotech or a large pharma company this event is the perfect platform to share challenges\, network with over 400 industry peers and hear informative case studies. \n2018 Key Speakers: \n– Chris Wallace\, Senior Director\, International Supply Chain Operations\, Genzyme\n– Clemens Twardy\, Head of Logistics\, Boehringer Ingelheim\n– Francisco Rizzuto\, Cargo Specialist\, IATA\n– Sven Sachsse\, Transport Expert – Supplier Qualification\, Bayer\n– Nicola Caristo\, Pharma Audit and Compliance Manager\, ALHA Group\n– Marc Sotty\, Studies and Distribution Head\, Sanofi \nTo learn more about this event\, and to register online\, visit http://www.arena-international.com/pharmatemp
URL:https://www.pharmajournalist.com/event/temperature-maintenance-biopharmaceuticals-distribution-2018/
LOCATION:Milan\, Italy
ORGANIZER;CN="Arena International Events Group":MAILTO:events@arena-international.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180319
DTEND;VALUE=DATE:20180321
DTSTAMP:20260515T074312
CREATED:20171023T082959Z
LAST-MODIFIED:20171023T084059Z
UID:3576-1521417600-1521590399@www.pharmajournalist.com
SUMMARY:20th Annual Superbugs & Superdrugs
DESCRIPTION:Providing a focal point to push industry collaboration through updates on clinical advancements and investment opportunities\, SMi presents the 20th annual Superbugs &Superdrugs conference which will return to Central London on 19th and 20th March 2018. \nThe threat of AMR is regularly making front page news but what is the industry actually doing? Are drug manufacturers any closer to finding a solution and how is the government helping? These will be just some of the questions answered through powerful keynote addresses delivered by an expert panel of scientific leaders\, drug discovery specialists and government bodies such as MHRA and DNDi. \nFEATURED SPEAKERS INCLUDE: \n– Richard Bax\, Senior Partner\, TranScrip Partners\n– Lloyd Czaplewski\, Director\, Chemical Biology Ventures\n– Mair Powell\, Senior clinical assessor\, MHRA\n– Jean-Pierre Paccaud\, Director of Business Development at GARDP\, Drugs for Neglected Diseases initiative (DNDi)\n– Conrad Lichtenstein\, CSO\, Nemesis bioscience\n– David Brown\, Managing Director and Founder\, Alchemy Biomedical Consulting\n– Domingo Gargallo-Viola\, Chief Scientific Officer\, ABAC Therapeutics\n– John George\, CSO\, Oppilotech\n– Larry Sutton\, Scientific Founder\, Gladius Pharmaceuticals\n– Kathy Talkington\, Project Director\, Pew charitable trusts\n– David Cook\, Chief Scientific Officer\, Blueberry Therapeutics\n– William Weiss\, Director of Pre-Clinical Services\, University of North Texas Health Science Center\n– Cara Cassino\, Chief Medical Officer\, ContraFect\n– Stephen Barat\, Head of Pre-Clinical and Early Clinical Development\, SCYNEXIS Inc \nWHATS ON THE AGENDA FOR 2018? \n– Analyze the current status of antimicrobial resistance with industry led insight into current strategies to tackle AMR\n– Hear exclusive case studies from a selection of pharmaceutical companies on clinical progress\n– Learn about regulatory pathways for the registration of new antimicrobial agents\n– Evaluate the latest incentives and funding solutions to spur drug discovery\n– Explore novel alternatives to antibiotics currently in development \nTo register visit www.superbugssuperdrugs.com/pjournalist \nFor enquires contact the team on +44 (0)207 827 6000 or email events@smi-online.co.uk
URL:https://www.pharmajournalist.com/event/20th-annual-superbugs-superdrugs/
LOCATION:Copthorne Tara Hotel\, Kensington\, London\, UK
ORGANIZER;CN="SMi Group Ltd":MAILTO:events@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180319
DTEND;VALUE=DATE:20180321
DTSTAMP:20260515T074312
CREATED:20171031T010129Z
LAST-MODIFIED:20171031T044056Z
UID:3637-1521417600-1521590399@www.pharmajournalist.com
SUMMARY:12th annual Paediatric Clinical
DESCRIPTION:SMi is pleased to present the return of their 12th annual Paediatric Clinical Trials Conference taking place on 19th – 20th March 2018\, London\, UK. \n \nClinical trials in paediatric populations still pose several challenges and often many studies remain un- published. 10 years on from the introduction of EU Paediatric Investigation Plans (PIPs) there are still many lessons to be learned about the planning and execution of trials which should be tailored around the needs of children. Recent advancements in immuno-oncology research has led to an increase in clinical trials to treat cancer in children and adolescents. Greater emphasis has also been placed on pain-free administration of drugs in the bid to increase vaccination uptake and access to medicines. \nJoin us as we discuss current clinical trials and the innovative digital technology being used to improve clinical recruitment and retention as well as improve the quality of data being collected. leading industry experts will be looking at how to work within regulations and foster the involvement of young people in their care. We will also be looking at the planning and executing a paediatric clinical trial and the ways this can vary according to region. We will be exploring the complexities of paediatric drug formulation and helping you determine clinical endpoints. \nReasons to attend Paediatric Clinical Trials 2018 \n– Regulatory keynote from the MHRA – The UK’s Early Access to Medicines Scheme (EAMS) and how this scheme benefits paediatric patients\n– Hear from Amgen and Roche as they give exclusive case studies on new approaches to recruitment\, retention\, and clinical trial design for rare diseases\n– Pfizer and Barcelona Children’s Hospital will be exploring how advancements in technology are facilitating improved clinical trials and data collection for paediatric drug development\n– AstraZeneca will be reviewing and discussing paediatric clinical trial Legislation in the EU and US.\n– There will be an exciting panel with the likes of GSK\, Roche and regulatory bodies debating challenges and opportunities 10 years on from paediatric regulation in the EU and potential changes on the horizon\n– There will be multiple pharmaceutical companies (UCB\, Sanofi and GSK) debating scenarios where data extrapolation and government incentives might increase access to medicines in paediatric populations.\n– Discover how to optimise your approach to clinical success through global collaboration being discussed by Takeda
URL:https://www.pharmajournalist.com/event/12th-annual-paediatric-clinical/
LOCATION:Copthorne Tara Hotel\, London\, UK
ORGANIZER;CN="SMi Group Ltd":MAILTO:kwilliams@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180320
DTEND;VALUE=DATE:20180322
DTSTAMP:20260515T074312
CREATED:20171204T074612Z
LAST-MODIFIED:20171204T074612Z
UID:4963-1521504000-1521676799@www.pharmajournalist.com
SUMMARY:7th Annual Clinical Data Integration & Management
DESCRIPTION:After the most successful Clinical Data Integration & Management conference to date\, we are excited to announce Arena International will be returning to Princeton in March 2018 for another epic event. \n \nThis year we brought together over 100 senior level professionals working within clinical data management to network and overcome some of the biggest challenges facing the industry. \nA highlight of our 2017 programme included an interactive panel discussion on the first day\, exploring how to achieve the right balance between increasing the data delivery speed whilst continuing to produce high quality data. Attendees had the opportunity to ask our 3 industry experts probing questions to uncover potential solutions to this challenge. \nDay 2 saw an engaging presentation from Johnson & Johnson\, addressing the wearable technologies currently being incorporated into clinical trials. They highlighted various examples of wearables as well as recognizing the challenges with moving towards these advanced technologies. This presentation was followed by a Q&A\, opening up the discussion to the audience. \nNext year’s ECDM event will be even better with more interactive sessions and content. We look forward to seeing you in Princeton next March! \nTo learn more about this event\, and to register online\, visit www.arena-international.com/ecdm/
URL:https://www.pharmajournalist.com/event/7th-annual-clinical-data-integration-management/
LOCATION:Princeton\,NJ
ORGANIZER;CN="Arena International":MAILTO:events@arena-international.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180320
DTEND;VALUE=DATE:20180322
DTSTAMP:20260515T074312
CREATED:20171214T080104Z
LAST-MODIFIED:20171214T080104Z
UID:5339-1521504000-1521676799@www.pharmajournalist.com
SUMMARY:PHARMA SECURITY WORLD 2018
DESCRIPTION:The Counterfeit medicines are turning into a serious concern around the world\, and have progressively been showing up through the real pharmaceutical supply chain\, including community and online drug stores. What’s more\, pharmaceutical companies and regulators are creating ways to stop them. No nations stay untouched by this issue\, what was once viewed as an issue endured by developing nations has now turned into an issue to developing nations including US and Europe. We require both countrywide and industry-level participation\, and in addition public and private sector coordinated effort\, to identify and definitively battle counterfeiters. To protect your brand and build a genuine future\, Corvus Global Events invites you to Pharma Security World 2018 – An Anti-counterfeiting & Brand Safety Conference\, which will have Pharma industry experts sharing various challenges faced\, new strategies\, case studies and use of innovative ideas and the conference will also offer opportunities to encourage partnerships and collaborations. \nTo learn more about this event\, and to register online\, visit http://bit.ly/2o5HD1M
URL:https://www.pharmajournalist.com/event/pharma-security-world-2018/
LOCATION:London\, UK
ORGANIZER;CN="Corvus Global Events Limited":MAILTO:info@corvusglobalevents.com/ fazmina@corvusglobalevents.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180321
DTEND;VALUE=DATE:20180323
DTSTAMP:20260515T074312
CREATED:20171019T103727Z
LAST-MODIFIED:20171019T103727Z
UID:3505-1521590400-1521763199@www.pharmajournalist.com
SUMMARY:Drug Discovery 
DESCRIPTION:SMi Group is proud to announce the return of Drug Discovery in 2018. The successful conference will return for its 2nd year on the 21st and 22nd March. \n \nThe pharmaceutical industry is constantly battling the same issue when trying to discover drugs; the process is timely\, expensive and usually unsuccessful. Pharma companies are trying to speed up the procedure to make it more accurate and minimise drug leads which are likely to fail further on in the drug development process. Consequently\, the event will focus on key developments in this very industry. \nSMi’s 2nd annual Drug Discovery conference provides an unprecedented opportunity to gain insight into the use of Artificial Intelligence in silico drug discovery\, CRISPR and PROTAC’s\, as well as discussing advancements in medicinal chemistry\, translational medicine and 3D structure based-discovery. \nWith huge interest from leaders in the field\, we have worked closely with an expert panel of speakers to present an agenda that is shaping up to be the best Drug Discovery yet. This year’s event will continue to lead with its unrivalled panel of experts bringing you the most insightful presentations from our confirmed Industry-leading speakers: \n– Chairman – Darren Green\, Director of Computational Chemistry and Informatics\, GlaxoSmithKline plc\n– Chairman – Guido Hanauer\, CEO\, GHPC GmbH\n– Steve Rees\, Vice-President\, Screening Sciences and Sample Management at AstraZeneca\, Astra Zeneca Plc\n– Claus Bendtsen\, Executive Director/Sr Leader Data Science\, AstraZeneca\n– Ralph Minter\, Director\, Fellow\, Antibody Discovery and Protein Engineering\, MedImmune\n– Stevan Djuric\, Vice President\, AbbVie\n– John Harling\, Director of Chemistry for the Protein Degradation DPU\, GlaxoSmithKline plc\n– Ursula Egner\, Director Process Simulation and Design Collaboration\, Bayer HealthCare \nEarly bird discounts! \n\nRegister by the 30th November to save £400\n15th December to save £200\n31st January to save £100
URL:https://www.pharmajournalist.com/event/drug-discovery/
LOCATION:Copthorne Tara Hotel\, London\, UK
ORGANIZER;CN="SMi Group Ltd":MAILTO:nboumediene@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180321
DTEND;VALUE=DATE:20180323
DTSTAMP:20260515T074312
CREATED:20171031T052535Z
LAST-MODIFIED:20171031T052710Z
UID:3711-1521590400-1521763199@www.pharmajournalist.com
SUMMARY:15th annual Controlled Release Delivery
DESCRIPTION:Building on the success of previous events\, SMi’s Controlled Release Delivery conference returns for its 15th year in London on 21-22 March 2018. \nAs physicians and scientists continue to find strategies to assist in simplifying treatment schedules for patients\, a pharma focus continues to move towards innovative controlled release technologies to improve drug transport to target. \nMoreover\, with the global oral controlled release drug delivery technology market expected to flourish in the next few years\, now is the time to get ahead of the game by exploring and understanding innovations in oral-lipid based and abuse deterrent formulations\, nanoparticles and nanotechnologies\, taste-masking and controlled release approaches\, 3D printed dosage forms and functional film coats. \nFeaturing presentations to analyse and evaluate latest advancements in drug delivery\, this year’s event highlights include: \n\nFormulation of Controlled Release Delivery Technologies and improving the design of new controlled release delivery systems\nInnovative additions to Oral Controlled Release Delivery Technologies\, to improve the pharmacokinetic-pharmacodynamic properties of the drug\nLatest regulation guidance and their implications for the pharmaceutical industry\nClinical developments and lessons learnt during clinical trials\, through case studies with top pharmaceutical companies\n\nFeatured speakers include senior decision makers and innovators from University of Strathclyde\, GSK\, Ipsen\, PLIVA\, SiTech Pharmabio\, Grunenthal\, Colorcon\, Bial\, Peptigel Design\, University of Central Lancashire and more! \nVisit www.controlledreleasedelivery.com/pharmajournalist to view the full list of speakers and their presentations. \nEARLY BIRD : Book by 30 November to save £400. Book by 15 December to save £200. Book by 31st January to save £100.
URL:https://www.pharmajournalist.com/event/15th-annual-controlled-release-delivery/
LOCATION:Copthorne Tara Hotel\, London\, UK
ORGANIZER;CN="SMi Group Ltd":MAILTO:hdegracia@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180321
DTEND;VALUE=DATE:20180324
DTSTAMP:20260515T074312
CREATED:20171205T022232Z
LAST-MODIFIED:20180103T070336Z
UID:4992-1521590400-1521849599@www.pharmajournalist.com
SUMMARY:ePharma
DESCRIPTION:Join more than 500 digital pharma marketers\, technologists\, and digital agencies at ePharma 2018 to discuss the ongoing digital evolution of marketing practices in pharma and biotech and the continual digitization of the patient and HCP journeys. \nePharma is a long-standing platform known to spark insightful conversations and inspire through instructional case studies\, out-of-industry perspectives\, and leading-edge technology\, providing attendees with strategies and tactics to grow as leaders\, embrace disruption\, and seize innovation. \nTo learn more about this event\, and to register online\, visit www.epharmasummit.com
URL:https://www.pharmajournalist.com/event/epharma/
LOCATION:New York Marriott Marquis
ORGANIZER;CN="Knect365%2C a division of Informa":MAILTO:frances.pratt@knect365.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180326
DTEND;VALUE=DATE:20180329
DTSTAMP:20260515T074312
CREATED:20180119T152310Z
LAST-MODIFIED:20180119T152348Z
UID:8111-1522022400-1522281599@www.pharmajournalist.com
SUMMARY:Pharma Anti-Counterfeiting & Brand Protection Summit
DESCRIPTION:More than 1 million people a year are dying from counterfeit drugs. In addition to this overwhelming social impact\, the economic effects threaten a profitable industry meant to provide life-saving drugs all over the world. Product recall costs\, lost sales and industry fines constantly plague industry operations. With the recent Drug Diversion and Counterfeit Crackdown Act of 2017 and Operation Pangea X\, awareness is at its peak and will continue to grow. It is time to join the conversation and push the issues forward at the Pharma Anti-Counterfeiting & Brand Protection Summit. Key opinion leaders will come together to help you build a more complete brand protection strategy. \n\nTo learn more about this event\, and to register online\, visit http://bit.ly/2BeKx5I
URL:https://www.pharmajournalist.com/event/pharma-anti-counterfeiting-brand-protection-summit/
LOCATION:Hilton Garden Inn Philadelphia Center City\, 1100 Arch Street\, Philadelphia\, Pennsylvania\, 19107\, United States
ORGANIZER;CN="IQPC":MAILTO:enquiryiqpc@iqpc.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180327
DTEND;VALUE=DATE:20180330
DTSTAMP:20260515T074312
CREATED:20180124T050058Z
LAST-MODIFIED:20180124T050555Z
UID:8343-1522108800-1522367999@www.pharmajournalist.com
SUMMARY:CPhI South East Asia
DESCRIPTION:CPhI South East Asia is a focused trade fair for Pharma industry\, serving the highly potential South East Asia market. Covering a complete\, end-to-end Pharma manufacturing supply chain from ingredients\, machinery & technology\, packaging\, contract services\, to analytical equipment\, the event is also held concurrently with Health ingredients (Hi) South East Asia which focuses on ingredients for functional food\, nutraceutical and nutrition. \nCPhI South East Asia emphasizes on networking\, knowledge and development opportunity. Through value-packed on site activities\, attendees are able to expand their business contacts\, meet new suppliers\, explore business opportunity\, enhance their knowledge and exchange experiences. \nJoin the exhibition\, conference\, forum\, exhibitor showcase\, focus groups\, business matchings\, and more. \n \nTo learn more about this event\, and to register online\, visit www.ubm.com/sea
URL:https://www.pharmajournalist.com/event/cphi-south-east-asia/
LOCATION:Jakarta International Expo\, Kemayoran\, Jakarta\, Indonesia
ORGANIZER;CN="PT UBM Pameran Niaga Indonesia":MAILTO:maria.lioe@ubm.com
END:VEVENT
END:VCALENDAR